FMP

FMP

Enter

ANTH - Anthera Pharmac...

photo-url-https://images.financialmodelingprep.com/symbol/ANTH.png

Anthera Pharmaceuticals, Inc.

ANTH

PNK

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

0.0001 USD

0 (0%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. John Craig Thompson

sector

Healthcare

industry

Biotechnology

exchange

PNK

Description

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

CIK

0001316175

ISIN

US03674U3005

CUSIP

03674U300

Address

The Pennzoil Building

Phone

410 350 1839

Country

US

Employee

21

IPO Date

Mar 1, 2010

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

ANTH Financial Summary

CIK

0001316175

Exchange

PNK

Industry

Biotechnology

Sector

Healthcare

CUSIP

03674U300

ISIN

US03674U3005

Country

US

Price

0

Beta

-123.12

Volume Avg.

3.99k

Market Cap

26

Shares

-

52-Week

1.0E-4-2.0E-4

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.01

P/B

-

Website

https://www.anthera.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest ANTH News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep